From Founder to Funder: Leen Kawas Reveals What Life Sciences Investors Actually Look For

Most advice about what venture capitalists want comes from people who've only sat on one side of the table.

Leen Kawas offers a different perspective—she's successfully navigated both sides of the life sciences funding equation.

As a founder, she co-founded and led a biotechnology company through its initial public offering, raising over $400 million in the process. She became one of only 22 women founders in the United States to take their company public. Now, as Managing General Partner at Propel Bio Partners, she's the one writing the checks, evaluating start-up and early-stage biotech companies seeking funding.

This dual experience gives Leen Kawas unique insights into what really matters when first-time founders pitch life sciences investors. The gap between what founders think VCs want and what VCs actually prioritize can make or break a funding round.

Read the Full Article Here